Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Non-Current Deferred Tax Liability (2023 - 2025)

Historic Non-Current Deferred Tax Liability for Coherus Oncology (CHRS) over the last 3 years, with Q3 2025 value amounting to $1.1 million.

  • Coherus Oncology's Non-Current Deferred Tax Liability changed 0.0% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.1 million for FY2024, which is 0.0% changed from last year.
  • Coherus Oncology's Non-Current Deferred Tax Liability amounted to $1.1 million in Q3 2025, which was down 0.0% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Non-Current Deferred Tax Liability ranged from a high of $1.1 million in Q3 2023 and a low of $1.1 million during Q3 2023
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $1.1 million (2023), whereas its average is $1.1 million.
  • Data for Coherus Oncology's Non-Current Deferred Tax Liability shows a peak YoY increase of 0.0% (in 2024) and a maximum YoY decrease of 0.0% (in 2024) over the last 5 years.
  • Over the past 3 years, Coherus Oncology's Non-Current Deferred Tax Liability (Quarter) stood at $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025.
  • Its Non-Current Deferred Tax Liability was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.